A double-blind cross-over trial of trimethoprim and sulphamethoxazole in chronic bronchitis
AUTOR(ES)
Webster, Ian W.
RESUMO
A double-blind cross-over trial comparing trimethoprim-sulphamethoxazole with sulphamethoxazole in patients with chronic bronchitis in their usual state of health showed that the combination was more effective in reducing the volume and purulence of the sputum. Although the patients preferred treatment with the combination, there was no objective improvement in respiratory function. There was a significant incidence of side effects.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1019090Documentos Relacionados
- Proceedings: Effects of natural oestrogens on blood clotting--a double-blind cross-over trial.
- A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial
- Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis.
- Double-blind cross-over comparison of aceclidine and pilocarpine in open-angle glaucoma.
- S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]
